Literature DB >> 6175817

The effects of captopril on rat aortic angiotensin-converting enzyme.

P Velletri, B L Bean.   

Abstract

Angiotensin -converting enzyme (ACE) activity was found to be present within the rat aorta using radioenzymatic techniques. Forty-two percent of the enzyme activity was localized within the tunica media. Using an equilibrium dialysis cell system that insured equal free captopril concentrations in both plasma and aorta, converting enzyme in both tissues was observed to possess similar dissociation constants for the inhibitor. Four daily intraperitoneal doses, but not a single dose, of captopril led to a persistent inhibition of aortic-converting enzyme 24 h after final drug administration. Plasma-converting enzyme activity was changed at this time. These results suggest that different pools of converting enzyme recover form captopril inhibition at different rates. The prolonged inhibition of aortic ACE is discussed in terms of drug accumulation within the vessel wall, and the effect of such accumulation on the persistent antihypertensive actions of captopril are also discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6175817     DOI: 10.1097/00005344-198203000-00022

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  12 in total

1.  Probable involvement of vascular angiotensin II formation in the beta 2-adrenoceptor-mediated facilitation of the neurogenic vasopressor response in the pithed rat.

Authors:  E Schlicker; K Erkens; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-11       Impact factor: 3.000

2.  Local formation of angiotensin II in the rat aorta: effect of endothelium.

Authors:  C Eglème; F Cressier; J M Wood
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739

3.  Role of the endothelium on the facilitatory effects of angiotensin I and angiotensin II on noradrenergic transmission in the caudal artery of the rat.

Authors:  D F Story; J Ziogas
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

4.  Effects of angiotensin I and angiotensin II in blood vessels: greater influence of converting enzyme activity in the rabbit basilar artery.

Authors:  A Zerrouk; M Auguet; S Delaflotte; P E Chabrier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

5.  Subendothelial beta 2-adrenoceptors in the rat vena cava: facilitation of noradrenaline release via local stimulation of angiotensin II synthesis.

Authors:  M Göthert; P Kollecker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-10       Impact factor: 3.000

6.  Angiotensin-converting enzyme labeled with [3H]captopril. Tissue localizations and changes in different models of hypertension in the rat.

Authors:  S K Wilson; D R Lynch; S H Snyder
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

7.  Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).

Authors:  D W Cushman; F L Wang; W C Fung; G J Grover; C M Harvey; R J Scalese; S L Mitch; J M DeForrest
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

Review 8.  Acute and chronic effects of angiotensin converting enzyme inhibitors on the essential hypertensive kidney.

Authors:  G P Reams; J H Bauer
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

9.  Altered function of pulmonary endothelium following monocrotaline-induced lung vascular injury in rats.

Authors:  K Ito; T Nakashima; K Murakami; T Murakami
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

10.  Angiotensin-like activity in resistance vessels. Immunocytochemical study in Chinese hamsters.

Authors:  R Taugner; C P Bührle; D Ganten; E Hackenthal; C Hardegg; G Hardegg; R Nobiling; T Unger
Journal:  Histochemistry       Date:  1983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.